Cargando…

Twelve-month effects of everolimus on renal and lung function in lung transplantation: differences in chronic lung allograft dysfunction phenotypes

BACKGROUND: Chronic lung allograft dysfunction (CLAD), a complication affecting the survival of lung transplanted patients, includes two clinical phenotypes: bronchiolitis obliterans syndrome (BOS) and restrictive allograft syndrome (RAS). Everolimus is used in CLAD because of its antiproliferative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patrucco, Filippo, Allara, Elias, Boffini, Massimo, Rinaldi, Mauro, Costa, Cristina, Albera, Carlo, Solidoro, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925948/ https://www.ncbi.nlm.nih.gov/pubmed/33717427 http://dx.doi.org/10.1177/2040622321993441

Ejemplares similares

Cellular and humoral cytomegalovirus immunity changes in one-year combined prophylaxis after lung transplantation: suggestions from and for clinical practice
por: Solidoro, Paolo, et al.
Publicado: (2020)

Tailored combined cytomegalovirus management in lung transplantation: a retrospective analysis
por: Solidoro, Paolo, et al.
Publicado: (2019)

Progressive Fibrosing Interstitial Lung Diseases: A Current Perspective
por: Albera, Carlo, et al.
Publicado: (2021)

Cytokines Removal During Ex-Vivo Lung Perfusion: Initial Clinical Experience
por: Boffini, Massimo, et al.
Publicado: (2023)

Safety of nintedanib before lung transplant: an Italian case series
por: Balestro, Elisabetta, et al.
Publicado: (2018)

Triple Therapy in COPD: Can We Welcome the Reduction in Cardiovascular Risk and Mortality?
por: Solidoro, Paolo, et al.
Publicado: (2022)

Validation of a Simple, Rapid, and Cost-Effective Method for Acute Rejection Monitoring in Lung Transplant Recipients
por: Sorbini, Monica, et al.
Publicado: (2022)

Idiopathic Pulmonary Fibrosis and Post-COVID-19 Lung Fibrosis: Links and Risks
por: Patrucco, Filippo, et al.
Publicado: (2023)

Lung retransplantation for chronic lung allograft dysfunction
por: Kosiorowska, Monika, et al.
Publicado: (2019)

Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation
por: Suwara, Monika I, et al.
Publicado: (2014)

Lung Ultrasound to Phenotype Chronic Lung Allograft Dysfunction in Lung Transplant Recipients. A Prospective Observational Study
por: Davidsen, Jesper Rømhild, et al.
Publicado: (2021)

Is there life on the airway tree? A pilot study of bronchial cell vitality and tissue morphology in the ex vivo lung perfusion (EVLP) era of lung transplantation
por: Boffini, Massimo, et al.
Publicado: (2022)

ALEMTUZUMAB FOR CHRONIC LUNG ALLOGRAFT DYSFUNCTION
por: Girgis, Reda, et al.
Publicado: (2020)

An update on chronic lung allograft dysfunction
por: Kotecha, Sakhee, et al.
Publicado: (2020)

Characterization of chronic lung allograft dysfunction phenotypes using spectral and intrabreath oscillometry
por: Fu, Anne, et al.
Publicado: (2022)

Lung Transplantation: CT Assessment of Chronic Lung Allograft Dysfunction (CLAD)
por: Brun, Anne-Laure, et al.
Publicado: (2021)

Systems prediction of chronic lung allograft dysfunction: Results and perspectives from the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction cohorts
por: Pison, Christophe, et al.
Publicado: (2023)

Infectious Triggers of Chronic Lung Allograft Dysfunction
por: Gregson, Aric L.
Publicado: (2016)

The Role of Galectins in Chronic Lung Allograft Dysfunction
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Lung Allograft Microbiome Association with Gastroesophageal Reflux, Inflammation, and Allograft Dysfunction
por: Schneeberger, Pierre H. H., et al.
Publicado: (2022)

Potential novel biomarkers for chronic lung allograft dysfunction and azithromycin responsive allograft dysfunction
por: Veraar, Cecilia, et al.
Publicado: (2021)

Chronic lung allograft dysfunction post-lung transplantation: The era of bronchiolitis obliterans syndrome and restrictive allograft syndrome
por: Yoshiyasu, Nobuyuki, et al.
Publicado: (2020)

Oesophageal stasis is a risk factor for chronic lung allograft dysfunction and allograft failure in lung transplant recipients
por: Ramendra, Rayoun, et al.
Publicado: (2023)

Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction
por: Rousselière, Amélie, et al.
Publicado: (2023)

MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction
por: Miyahara, Naofumi, et al.
Publicado: (2022)

Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review
por: Bos, Saskia, et al.
Publicado: (2021)

Multiple Colonic Submucosal Tumors in a Patient with Chronic Lung Allograft Dysfunction
por: Antonini, Filippo, et al.
Publicado: (2014)

Risk of Lung Allograft Dysfunction Associated With Aspergillus Infection
por: Le Pavec, Jérôme, et al.
Publicado: (2021)

Lung Allograft Dysfunction: Does Aspiration Hold the Key?
por: Pragman, Alexa A.
Publicado: (2022)

Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunction
por: Misumi, Keizo, et al.
Publicado: (2020)

Lung perfusion scintigraphy to detect chronic lung allograft dysfunction after living-donor lobar lung transplantation
por: Yamamoto, Haruchika, et al.
Publicado: (2020)

Awake or intubated surgery in diagnosis of interstitial lung diseases? A prospective study
por: Guerrera, Francesco, et al.
Publicado: (2021)

Symptomatic Respiratory Virus Infection and Chronic Lung Allograft Dysfunction
por: Fisher, Cynthia E., et al.
Publicado: (2016)

Coronavirus and Chronic Lung Allograft Dysfunction: Hiding in Plain Sight?
por: Mitchell, Alicia B., et al.
Publicado: (2018)

Early Identification of Chronic Lung Allograft Dysfunction: The Need of Biomarkers
por: Tissot, Adrien, et al.
Publicado: (2019)

Outcomes Following ATG Therapy for Chronic Lung Allograft Dysfunction
por: Kotecha, Sakhee, et al.
Publicado: (2021)

Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction
por: Bennett, David, et al.
Publicado: (2022)

Biomarkers for Chronic Lung Allograft Dysfunction: Ready for Prime Time?
por: Verleden, Stijn E., et al.
Publicado: (2022)

Alemtuzumab as a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short Telomeres
por: Trindade, Anil J., et al.
Publicado: (2020)

Quantitative CT Correlates with Local Inflammation in Lung of Patients with Subtypes of Chronic Lung Allograft Dysfunction
por: Ram, Sundaresh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_idbtrvm8epnt6efkffu53i7ul8